Oral contraceptive use and bone density in adolescent and young adult women

Contraception

Volumn 81, Issue 1, 2010, Pages 35-40

  Scholes, Delia ^a   Ichikawa, Laura ^a   LaCroix, Andrea Z ^a,b   Spangler, Leslie ^a   Beasley, Jeannette M ^a,b   Reed, Susan ^a,c   Ott, Susan M ^d  

^a CENTER FOR HEALTH STUDIES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adolescents; Bone mineral density; Hormones; Oral contraceptives; Peak bone density

Indexed keywords

ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; SIDE EFFECT; SPINE; TREATMENT DURATION; WHOLE BODY IMAGING;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; BONE DENSITY; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIP; HUMANS; REGRESSION ANALYSIS; SPINE;

EID: 71149097467     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.07.001     Document Type: Article

References (37)

1. Chandra A., Martinez G.M., Mosher W.D., Abma J.C., and Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23 (2005) 1-160
2. Martins S.L., Curtis K.M., and Glasier A.F. Combined hormonal contraception and bone health: a systematic review. Contraception 73 (2006) 445-469
3. Hartard M., Kleinmond C., Wiseman M., Weissenbacher E.R., Felsenberg D., and Erben R.G. Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone 40 (2007) 444-450
4. Polatti F., Perotti F., Filippa N., Gallina D., and Nappi R.E. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 51 (1995) 221-224
5. Register T.C., Jayo M.J., and Jerome C.P. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys. Osteoporos Int 7 (1997) 348-353
6. Recker R.R., Davies K.M., Hinders S.M., Heaney R.P., Stegman M.R., and Kimmel D.B. Bone gain in young adult women. JAMA 268 (1992) 2403-2408
7. Nappi C., Di Spiezio Sardo A., Greco E., Tommaselli G.A., Giordano E., and Guida M. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol 105 (2005) 53-60
8. Reed S.D., Scholes D., LaCroix A.Z., Ichikawa L., Barlow W.E., and Ott S.M. Longitudinal changes in bone density in relation to oral contraceptive use. Contraception 68 (2003) 177-182
9. Cromer B.A., Bonny A.E., Stager M., et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril 90 (2008) 2060-2067
10. Petitti D.B., Piaggio G., Mehta S., Cravioto M.C., and Meirik O. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet Gynecol 95 (2000) 736-744
11. Lloyd T., Taylor D.S., Lin H.M., Matthews A.E., Eggli D.F., and Legro R.S. Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study. Fertil Steril 74 (2000) 734-738
12. Prior J.C., Kirkland S.A., Joseph L., et al. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. Can Med Assoc J 165 (2001) 1023-1029
13. Cromer B.A., Stager M., Bonny A., et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 35 (2004) 434-441
14. Almstedt Shoepe H., and Snow C.M. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. Osteoporos Int 16 (2005) 1538-1544
15. Berenson A.B., Rahman M., Breitkopf C.R., and Bi L.X. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet Gynecol 112 (2008) 788-799
16. Pikkarainen E., Lehtonen-Veromaa M., Mottonen T., Kautiainen H., and Viikari J. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study. Contraception 78 (2008) 226-231
17. Beksinska M.E., Kleinschmidt I., Smit J.A., and Farley T.M. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraception 79 (2009) 345-349
18. O'Brien S.H., Kaizar E.E., Gold M.A., and Kelleher K.J. Trends in prescribing patterns of hormonal contraceptives for adolescents. Contraception 77 (2008) 264-269
19. Patterson R.E., Kristal A.R., Tinker L.F., Carter R.A., Bolton M.P., and Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 9 (1999) 178-187
20. Marcus A.C. Memory aids in longitudinal health surveys: results from a field experiment. Am J Public Health 72 (1982) 567-573
21. Coulter A., Vessey M., McPherson K., and Crossley B. The ability of women to recall their oral contraceptive histories. Contraception 33 (1986) 127-137
22. Cook L.S., White J.L., Stuart G.C., and Magliocco A.M. The reliability of telephone interviews compared with in-person interviews using memory aids. Ann Epidemiol 13 (2003) 495-501
23. Ott S.M., Ichikawa L.E., LaCroix A.Z., and Scholes D. Navel jewelry artifacts and intravertebral variation in spine bone densitometry in adolescents and young women. J Clin Densitom 12 (2009) 84-88
24. Parsons T.J., Prentice A., Smith E.A., Cole T.J., and Compston J.E. Bone mineral mass consolidation in young British adults. J Bone Miner Res 11 (1996) 264-274
25. Henry Y.M., Fatayerji D., and Eastell R. Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 15 (2004) 263-273
26. Mah P.M., Webster J., Jonsson P., Feldt-Rasmussen U., Koltowska-Haggstrom M., and Ross R.J. Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab 90 (2005) 5964-5969
27. Mishell D.R.J., Thorneycroft I.H., Nakamura R.M., Nagata Y., and Stone S.C. Serum estradiol in women ingesting combination oral contraceptive steroids. Am J Obstet Gynecol 114 (1972) 923-928
28. Spona J., Elstein M., Feichtinger W., et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 54 (1996) 71-77
29. Perry R.J., Farquharson C., and Ahmed S.F. The role of sex steroids in controlling pubertal growth. Clin Endocrinol (Oxf) 68 (2008) 4-15
30. Vanderschueren D., Venken K., Ophoff J., Bouillon R., and Boonen S. Clinical review: sex steroids and the periosteum - reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab 91 (2006) 378-382
31. Walsh J.S., Eastell R., and Peel N.F. Effects of depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J Clin Endocrinol Metab 93 (2008) 1317-1323
32. van der Eerden B.C., Karperien M., and Wit J.M. Systemic and local regulation of the growth plate. Endocr Rev 24 (2003) 782-801
33. Lopez L.M., Grimes D.A., Schulz K.F., and Curtis K.M. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev (2009) CD006033
34. Cooper C., Hannaford P., Croft P., and Kay C.R. Oral contraceptive pill use and fractures in women: a prospective study. Bone 14 (1993) 41-45
35. Vessey M., Mant J., and Painter R. Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study. Contraception 57 (1998) 231-235
36. Vestergaard P., Rejnmark L., and Mosekilde L. Fracture risk in very young women using combined oral contraceptives. Contraception 78 (2008) 358-364
37. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18 (2007) 1033-1046